BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25774566)

  • 1. Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study.
    Hammond FM; Sherer M; Malec JF; Zafonte RD; Whitney M; Bell K; Dikmen S; Bogner J; Mysiw J; Pershad R;
    J Neurotrauma; 2015 Aug; 32(16):1230-8. PubMed ID: 25774566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression.
    Hammond FM; Bickett AK; Norton JH; Pershad R
    J Head Trauma Rehabil; 2014; 29(5):391-9. PubMed ID: 24263176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Impact of Amantadine on Aggression in Chronic Traumatic Brain Injury.
    Hammond FM; Malec JF; Zafonte RD; Sherer M; Bogner J; Dikmen S; Whitney MP; Bell KR; Perkins SM; Moser EA
    J Head Trauma Rehabil; 2017; 32(5):308-318. PubMed ID: 28891908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine for Irritability and Aggression after Traumatic Brain Injury: A Randomized, Placebo-Controlled Study.
    Hammond FM; Zafonte RD; Tang Q; Jang JH
    J Neurotrauma; 2021 Aug; 38(16):2238-2246. PubMed ID: 33563104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
    Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Clinically Important Difference for the Rasch Neuropsychiatric Inventory Irritability and Aggression Scale for Traumatic Brain Injury.
    Malec JF; Hammond FM
    Arch Phys Med Rehabil; 2018 Mar; 99(3):603-606.e1. PubMed ID: 28918102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.
    Meythaler JM; Brunner RC; Johnson A; Novack TA
    J Head Trauma Rehabil; 2002 Aug; 17(4):300-13. PubMed ID: 12105999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial.
    Hammond FM; Sherer M; Malec JF; Zafonte RD; Dikmen S; Bogner J; Bell KR; Barber J; Temkin N
    J Neurotrauma; 2018 Oct; 35(19):2298-2305. PubMed ID: 29742960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled trial of amantadine for severe traumatic brain injury.
    Giacino JT; Whyte J; Bagiella E; Kalmar K; Childs N; Khademi A; Eifert B; Long D; Katz DI; Cho S; Yablon SA; Luther M; Hammond FM; Nordenbo A; Novak P; Mercer W; Maurer-Karattup P; Sherer M
    N Engl J Med; 2012 Mar; 366(9):819-26. PubMed ID: 22375973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of amantadine on behavioural problems due to acquired brain injury: A systematic review.
    Ter Mors BJ; Backx APM; Spauwen P; Ponds RWHM; Van Harten PN; Van Heugten CM
    Brain Inj; 2019; 33(9):1137-1150. PubMed ID: 31250669
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury.
    Al-Adawi S; Hoaglin H; Vesali F; Dorvlo AS; Burke DT
    Brain Inj; 2009 Jun; 23(6):559-65. PubMed ID: 19484629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasch Analysis, Dimensionality, and Scoring of the Neuropsychiatric Inventory Irritability and Aggression Subscales in Individuals With Traumatic Brain Injury.
    Malec JF; Stump TE; Monahan PO; Kean J; Neumann D; Hammond FM
    Arch Phys Med Rehabil; 2018 Feb; 99(2):281-288.e2. PubMed ID: 28918103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical complications during inpatient rehabilitation among patients with traumatic disorders of consciousness.
    Whyte J; Nordenbo AM; Kalmar K; Merges B; Bagiella E; Chang H; Yablon S; Cho S; Hammond F; Khademi A; Giacino J
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1877-83. PubMed ID: 23735519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study.
    Schneider WN; Drew-Cates J; Wong TM; Dombovy ML
    Brain Inj; 1999 Nov; 13(11):863-72. PubMed ID: 10579658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury.
    Shimia M; Iranmehr A; Valizadeh A; Mirzaei F; Namvar M; Rafiei E; Rahimi A; Khadivi A; Aeinfar K
    J Neurosurg Sci; 2023 Oct; 67(5):598-604. PubMed ID: 34114429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.
    Giacino JT; Whyte J
    J Head Trauma Rehabil; 2003; 18(1):4-5; author reply 5-6. PubMed ID: 12809123
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
    Cohen JA; Hunter SF; Brown TR; Gudesblatt M; Thrower BW; Llorens L; Souza-Prien CJ; Ruby AE; Chernoff DN; Patni R
    Mult Scler; 2019 Apr; 25(4):601-609. PubMed ID: 29368539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the benefits and risks of amantadine for irritability and aggression after traumatic brain injury.
    Hammond FM; Zafonte RD; Sherer M; Bell KR; Bogner J; Malec JF; Tang Q; Jang JH
    PM R; 2023 Dec; ():. PubMed ID: 38145314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.